Ireny Iskandar

Dr

Personal profile

Overview

My research is focused on biologic therapies in moderate-to-severe plaque psoriasis. The main area of work will involve assessing the clinical effectiveness of biologic therapies under real life conditions, outside the context of randomised trial. This would involve directly comparing the three biologic therapies (etanercept, adalimumab and ustekinumab) currently approved in the UK for the treatment of moderate-to-severe plaque psoriasis regarding treatment responses and induction of remission in a large longitudinal observational cohort study. Furthermore, I aim to identify specific demographic and clinical factors that correlate with response to the biologic therapies. The psoriasis population data will be utilised from the British Association of Dermatologists Biologic Interventions Register (BADBIR), a UK and Republic of Ireland based prospective, longitudinal, observational web-based pharmacovigilance register.

Biography

I graduated from Cairo University in 2012 with BSc (Honours with distinction) degree in Pharmacy and Pharmaceutical Sciences (Clinical Pharmacy). During this time, I was given the opportunity to work as a teaching assistant within the Clinical Pharmacy department; which sparked my interest in medical statistics and pharmacoepidemiology. In September 2013, I was awarded with the President's Doctoral Scholars award from the University of Manchester to develop skills in pharmacoepidemiological research whilst examining the use of biologic therapies in the management of psoriasis. I completed my PhD in August 2017.

Qualifications

August 2017: PhD in Pharmacoepidemiology, Division of Pharmacy and Optometry, University of Manchester, Manchester, U.K.

July 2012: Bsc in Pharmacy and Pharmaceutical Sciences (Clinical Pharmacy) cGPA: 3.99 (A-) out of 4.00, Honours with distinctions - 1st class degree (ranked as 1st in my class), Faculty of Pharmacy, Cairo University, Cairo, Egypt.

 

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research Beacons, Institutes and Platforms

  • Thomas Ashton Institute

Keywords

  • Pharmacoepidemiology
  • Biologic therapies
  • psoriasis
  • Epidemiology
  • Biostatistics

Fingerprint

Dive into the research topics where Ireny Iskandar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or